Advertisement

---

SYNDAX PHARMACEUTICALS, INC.

Syndax Pharmaceuticals Announces Publication of Clinical Study Demonstrating that Entinostat Targets Resistance Pathways in Breast Cancer

[2013-05-14] - --Results Published in Journal of Clinical Oncology Show for the First Time that Adding Entinostat to Antiestrogen Therapy May Be an Effective Approach to Targeting Resistance Pathways in Breast Cancer--


Advertisement
Most read: scientific news

More:

---


---
Follow us...

google plus Facebook twitter Newsletter

---


---

Plan du site

Actualités

Actualités

Actualités

Réglementaire

Emploi

Annuaires

Dictionnaire

Divers